Various references have previously been made to the $300m in these links :
https://www.fnarena.com/index.php/2017/05/30/customer-dispute-overshadows-sigma/
https://www.allangray.com.au/b/index.php/investing-in-the-face-of-uncertainty/
https://www.uwj.com.au/tag/sig/
As I mentioned elsewhere, I'm having trouble distinguishing whether there is in fact $300m to be 'returned', or it is merely the avoidance of investing $300m (extra?) as working capital under what would have been a new contract.
News: SIG Australia's Sigma Healthcare loses pharma contract to NZ's EBOS, page-9
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.89 |
Change
0.110(3.96%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.82 | $2.92 | $2.76 | $22.11M | 7.733M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 509791 | $2.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.90 | 226186 | 6 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
